There are no US FDA-approved therapies for the management of frontotemporal dementia (FTD). Evidence-based medicine that would support a FDA indication for the treatment of FTD requires large-scale, r READ MORE http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172080/